Improvement in liver function in patients with cirrhosis after transfusion of autologous bone marrow cells

References

[1] Махов В.М. Цирроз печени. Из: Маколкин В.И., Овчаренко С.И. Внутренние болезни. 2005; М.: Медицина: 352-65.

[2] Heidelbaugh J.J., Bruderly M. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. Am. Fam. Physician. 2006; 74(5): 756-62.

[3] Heidelbaugh J.J., Sherbondy M. Cirrhosis and chronic liver failure: part II. Complications and treatment. Am. Fam. Physician. 2006; 74(5): 767-76.

[4] Strom S., Fisher R. Hepatocyte transplantation: new possibilities for therapy. Gastroenterol. 2003; 124(2): 568-71.

[5] Fang B., Shi M., Liao L. et al. Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplant. 2004; 78(1): 83-8.

[6] Am Esche II J.S., Knoefel W.T., Klein M. et al. Portal application of autologous CD133+ bone marrow cells to the liver: A novel concept to support hepatic regeneration. Stem Cells 2005; 23: 463-70.

[7] Terai S., Sakaida I., Yamamoto N. et al. An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes. J. Biochem.(Tokyo) 2003; 134: 551-8.

[8] Russo F.P., Alison M.R., Bigger B.W. et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterol. 2006; 130(6): 1807-21.

[9] Iredale J.P. Hepatic stellate cell behavior during resolution of liver injury. Semin. Liver Dis. 2001; 21(3): 427-36.

RIGHTS & PERMISSIONS

Eco-Vector